Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus

被引:277
作者
Hong Y.-K. [1 ]
Foreman K. [2 ]
Shin J.W. [1 ]
Hirakawa S. [1 ]
Curry C.L. [2 ]
Sage D.R. [3 ]
Libermann T. [4 ]
Dezube B.J. [3 ]
Fingeroth J.D. [3 ]
Detmar M. [1 ]
机构
[1] Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129
[2] Loyola University Medical Center, Maywood
[3] Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston
[4] BIDMC Genomics Center, Department of Medicine, Harvard Medical School, Boston
关键词
D O I
10.1038/ng1383
中图分类号
学科分类号
摘要
Kaposi sarcoma is considered a neoplasm of lymphatic endothelium infected with Kaposi sarcoma-associated herpesvirus. It is characterized by the expression of lymphatic lineage-specific genes by Kaposi sarcoma tumor cells. Here we show that infection of differentiated blood vascular endothelial cells with Kaposi sarcoma-associated herpesvirus leads to their lymphatic reprogramming; induction of ∼70% of the main lymphatic lineage-specific genes, including PROX1, a master regulator of lymphatic development; and downregulation of blood vascular genes.
引用
收藏
页码:683 / 685
页数:2
相关论文
共 15 条
[1]  
Chang Y., Et al., Science, 266, pp. 1865-1869, (1994)
[2]  
Schalling M., Ekman M., Kaaya E.E., Linde A., Biberfeld P., Nat. Med., 1, pp. 707-708, (1995)
[3]  
Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M.C., Cesarman E., Nature, 385, pp. 347-350, (1997)
[4]  
Beckstead J.H., Wood G.S., Fletcher V., Am. J. Pathol., 119, pp. 294-300, (1985)
[5]  
Jussila L., Et al., Cancer Res., 58, pp. 1599-1604, (1998)
[6]  
Weninger W., Et al., Lab. Invest., 79, pp. 243-251, (1999)
[7]  
Skobe M., Et al., J. Invest. Dermatol., 113, pp. 1047-1053, (1999)
[8]  
Wigle J.T., Et al., EMBO J., 21, pp. 1505-1513, (2002)
[9]  
Hong Y.-K., Et al., Dev. Dyn., 225, pp. 351-357, (2002)
[10]  
Petrova T.V., Et al., EMBO J., 21, pp. 4593-4599, (2002)